Bausch Health
582 hedge funds and large institutions have $64.4B invested in Bausch Health in 2015 Q2 according to their latest regulatory filings, with 85 funds opening new positions, 186 increasing their positions, 224 reducing their positions, and 55 closing their positions.
55% more first-time investments, than exits
New positions opened: 85 | Existing positions closed: 55
12% more capital invested
Capital invested by funds: $57.6B → $64.4B (+$6.74B)
5% more funds holding
Funds holding: 556 → 582 (+26)
2% more funds holding in top 10
Funds holding in top 10: 87 → 89 (+2)
0.39% more ownership
Funds ownership: 84.48% → 84.87% (+0.39%)
17% less repeat investments, than reductions
Existing positions increased: 186 | Existing positions reduced: 224
54% less call options, than puts
Call options by funds: $889M | Put options by funds: $1.94B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Paulson & Co
New York
|
+$1.54B |
| 2 |
HP
Hound Partners
New York
|
+$607M |
| 3 |
VAM
Visium Asset Management
New York
|
+$182M |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$174M |
| 5 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
+$142M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VH
ValueAct Holdings
San Francisco,
California
|
-$973M |
| 2 |
Barclays
London,
United Kingdom
|
-$484M |
| 3 |
D.E. Shaw & Co
New York
|
-$298M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$120M |
| 5 |
IC
Institutional Capital
Chicago,
Illinois
|
-$118M |
BHC Hedge Fund Activity: Q2 2015 in Review
582 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q2 2015, worth a combined $64.4B — up 12% from $57.6B a quarter earlier.
Buyers outnumbered sellers: 85 funds opened new BHC positions and 55 closed out — a net gain of 30 holders — while 186 added to existing stakes and 224 trimmed.
The largest buyer was Paulson & Co, adding an estimated $1.54B. The largest seller was ValueAct Holdings, cutting an estimated $973M.
- 582 institutional investors held Bausch Health (BHC) as of Q2 2015, up from 556 in Q1 2015.
- Funds reported $64.4B of Bausch Health stock for Q2 2015, up 12% quarter-over-quarter.
- 85 funds opened new Bausch Health positions in Q2 2015 and 55 closed out, a net change of +30 holders.
- The largest Bausch Health buyer in Q2 2015 was Paulson & Co, an estimated $1.54B added.
- The largest Bausch Health seller in Q2 2015 was ValueAct Holdings, an estimated $973M sold.
Based on aggregated 13F filings for Q2 2015.